EU: possible green light in December for Moderna and Pfizer / BioNTech vaccines

The European Medicines Agency is “in daily discussions” with its American counterpart to “synchronize their evaluations”, says Ursula von der Leyen.

The European regulator could give the green light from mid-December to market the anti-COVID vaccines developed by the American start-up Moderna and by the Pfizer / BioNTech alliance, announced Thursday the President of the European Commission Ursula von der Leyen.

The European Medicines Agency (EMA) is “in daily discussions” with its American counterpart, the FDA, to “synchronize their evaluations”, and the EMA could “give conditional authorization to market Pfizer’s vaccines / BioNTech and Moderna from the second half of December, if the procedures go smoothly, ”said the head of the European executive at the end of a summit of the Twenty-Seven by videoconference dedicated to the pandemic.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.